David Allsop - Publications & Outputs - Research Portal

Professor David Allsop

Formerly at Lancaster University

76 - 100 out of 154Page size: 25

RSS feed of this list

Sort by: Type

Journal article
Published
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease.
Tokuda, T., Salem, S. A., Allsop, D., Mizuno, T., Nakagawa, M., Qureshi, M. M., Locascio, J. J., Schlossmacher, M. G. & El-Agnaf, O., 13/10/2006, In: Biochemical and Biophysical Research Communications. 349, 1, p. 162-166 5 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Donepezil for severe Alzheimer's disease.
Allsop, D., Martin, F., Moore, S. & Fullwood, N. J., 29/07/2006, In: Lancet. 368, 9533, p. 361-362 2 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on β-amyloid and α-synuclein.
Tabner, B. J., Turnbull, S., King, J., Benson, F. E., El-Agnaf, O. M. A. & Allsop, D., 07/2006, In: Free Radical Research. 40, 7, p. 731-739 9 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease
El-Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G. & Allsop, D., 2006, In: FASEB Journal. 20, 3, p. 419-425 7 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Protein aggregation, metals and oxidative stress in neurodegenerative diseases.
Tabner, B. J., El-Agnaf, O. M. A., German, M. J., Fullwood, N. J. & Allsop, D., 11/2005, In: Biochemical Society Transactions. 33, 5, p. 1082-1086 5 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer's disease and familial British dementia.
Tabner, B. J., El-Agnaf, O. M. A., Turnbull, S., German, M. J., Paleologou, K. E., Hayashi, Y., Cooper, L. J., Fullwood, N. & Allsop, D., 28/10/2005, In: Journal of Biological Chemistry. 280, 43, p. 35789-35792 4 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
The production of hydrogen peroxide during early-stage protein aggregation: a common pathological mechanism in different neurodegenerative diseases?
Tabner, B., Turnbull, S., Fullwood, N. J., German, M. & Allsop, D., 08/2005, In: Biochemical Society Transactions. 33, 4, p. 548-550 3 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
El-Agnaf, O. M. A., Paleologou, K. E., Greer, B., Abogrein, A. M., King, J., Salem, S. A., Fullwood, N. J., Benson, F. E., Hewitt, R., Ford, K. J., Martin, F., Harriott, P., Cookson, M. R. & Allsop, D., 08/2004, In: FASEB Journal. 18, 11, p. 1315-1317 3 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Both the D-(+) and L-(-) enantiomers of nicotine inhibit Aβ aggregation and cytotoxicity.
Moore, S. A., Huckerby, T. N., Gibson, G. L., Fullwood, N. J., Turnbull, I., Tabner, B. J., El-Agnaf, O. M. A. & Allsop, D., 01/2004, In: Biochemistry. 43, 3, p. 819-826 8 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
α-Synuclein and the pathogenesis of Parkinson’s disease.
Martin, F., Allsop, D., Williamson, S. J. M., Paleologou, K. E. & El-Agnaf, O. M. A., 2004, In: Protein and Peptide Letters. 11, 3, p. 229-237 9 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Induction of cellular oxidative stress by the β-amyloid peptide involved in Alzheimer's disease.
Gibson, G. L., Allsop, D. & Austen, B. M., 2004, In: Protein and Peptide Letters. 11, 3, p. 257-270 14 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Fe(II)-induced DNA damage in α-synuclein-transfected human dopaminergic BE(2)-M17 neuroblastoma cells: detection by the Comet assay.
Martin, F., Williamson, S. J. M., Paleologou, K. E., Hewitt, R., El-Agnaf, O. M. A. & Allsop, D., 11/2003, In: Journal of Neurochemistry. 87, 3, p. 620-630 11 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
α-Synuclein implicated in Parkinson’s disease is present in extracellular biological fluids, including human plasma.
El-Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J., Curran, M. D., Court, J. A., Mann, D. M. A., Ikeda, S-I., Cookson, M. R., Hardy, J. & Allsop, D., 10/2003, In: FASEB Journal. 17, 13, p. 1945-1947 3 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Quinacrine acts as an antioxidant and reduces the toxicity of the prion peptide PrP106-126.
Turnbull, S., Tabner, B. J., Brown, D. R. & Allsop, D., 15/09/2003, In: NeuroReport. 14, 13, p. 1743-1745 3 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Soluble oligomers for the diagnosis of neurodegenerative diseases.
El-Agnaf, O. M. A., Walsh, D. M. & Allsop, D., 08/2003, In: Lancet Neurology. 2, 8, p. 461-462 2 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Generation of hydrogen peroxide from mutant forms of the prion protein fragment PrP121-231.
Turnbull, S., Tabner, B. J., Brown, D. R. & Allsop, D., 1/07/2003, In: Biochemistry. 42, 25, p. 7675-7681 7 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Copper-dependent generation of hydrogen peroxide from the toxic prion protein fragment PrP106-126.
Turnbull, S., Tabner, B. J., Brown, D. R. & Allsop, D., 23/01/2003, In: Neuroscience Letters. 336, 3, p. 159-162 4 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Direct production of reactive oxygen species from aggregating proteins and peptides implicated in the pathogenesis of neurodegenerative diseases.
Tabner, B. J., Turnbull, S., El-Agnaf, O. M. A. & Allsop, D., 2003, In: Current Medicinal Chemistry Immunology Endocrine and Metabolic Agents. 3, 4, p. 299-308 10 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease.
Tabner, B. J., Turnbull, S., El-Agnaf, O. M. A. & Allsop, D., 1/06/2002, In: Free Radical Biology and Medicine. 32, 11, p. 1076-1083 8 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Inherited frontotemporal dementia in 9 British families associated with intronic mutations in the tau gene.
Pickering-Brown, S. M., Richardson, A. M. T., Snowden, J. S., McDonagh, A., Burns, A., Braudie, W., Baker, M., Yen, S-H., Hardy, J., Hutton, M., Davies, Y., Allsop, D., Craufurd, D., Neary, D. & Mann, D. M. A., 04/2002, In: Brain. 125, 4, p. 732-751 20 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Fluorescence anisotropy: a method for early detection of Alzheimer β-peptide (Aβ) aggregation.
Allsop, D., Swanson, L., Moore, S., Davies, Y., York, A., El-Agnaf, O. M. A. & Soutar, I., 6/07/2001, In: Biochemical and Biophysical Research Communications. 285, 1, p. 58-63 6 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
New evidence that the Alzheimer β-amyloid peptide does not spontaneously form free radicals: An ESR study using a series of spin-traps.
Turnbull, S., Tabner, B. J., El-Agnaf, O. M. A., Twyman, L. J. & Allsop, D., 15/05/2001, In: Free Radical Biology and Medicine. 30, 10, p. 1154-1162 9 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro.
Turnbull, S., Tabner, B. J., Moore, S., Davies, Y., El-Agnaf, O. M. A. & Allsop, D., 15/05/2001, In: Free Radical Biology and Medicine. 30, 10, p. 1163-1170 8 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
3-p-toluoyl-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran and 2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran do not act as surfactants or micelles when inhibiting the aggregation of β-amyloid peptide.
Allsop, D., Gibson, G., Martin, I. K., Moore, S., Turnbull, S. & Twyman, L. J., 01/2001, In: Bioorganic and Medicinal Chemistry Letters. 11, 2, p. 255-257 3 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
Tabner, B. J., Turnbull, S., El-Agnaf, O. M. A. & Allsop, D., 2001, In: Current Topics in Medicinal Chemistry. 1, p. 483-493 11 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review

Previous 1 2 3 4 5 6 7 Next

Research

Professor David Allsop

Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease.

Donepezil for severe Alzheimer's disease.

A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on β-amyloid and α-synuclein.

Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease

Protein aggregation, metals and oxidative stress in neurodegenerative diseases.

Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer's disease and familial British dementia.

The production of hydrogen peroxide during early-stage protein aggregation: a common pathological mechanism in different neurodegenerative diseases?

A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.

Both the D-(+) and L-(-) enantiomers of nicotine inhibit Aβ aggregation and cytotoxicity.

α-Synuclein and the pathogenesis of Parkinson’s disease.

Induction of cellular oxidative stress by the β-amyloid peptide involved in Alzheimer's disease.

Fe(II)-induced DNA damage in α-synuclein-transfected human dopaminergic BE(2)-M17 neuroblastoma cells: detection by the Comet assay.

α-Synuclein implicated in Parkinson’s disease is present in extracellular biological fluids, including human plasma.

Quinacrine acts as an antioxidant and reduces the toxicity of the prion peptide PrP106-126.

Soluble oligomers for the diagnosis of neurodegenerative diseases.

Generation of hydrogen peroxide from mutant forms of the prion protein fragment PrP121-231.

Copper-dependent generation of hydrogen peroxide from the toxic prion protein fragment PrP106-126.

Direct production of reactive oxygen species from aggregating proteins and peptides implicated in the pathogenesis of neurodegenerative diseases.

Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease.

Inherited frontotemporal dementia in 9 British families associated with intronic mutations in the tau gene.

Fluorescence anisotropy: a method for early detection of Alzheimer β-peptide (Aβ) aggregation.

New evidence that the Alzheimer β-amyloid peptide does not spontaneously form free radicals: An ESR study using a series of spin-traps.

α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro.

3-p-toluoyl-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran and 2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran do not act as surfactants or micelles when inhibiting the aggregation of β-amyloid peptide.

Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.

Quick Links

Connect With Us

Faculties & Depts

Contact Us